1. Signaling Pathways
  2. Epigenetics
  3. Histone Methyltransferase
  4. SETD2/KMT3A Isoform
  5. SETD2/KMT3A Inhibitor

SETD2/KMT3A Inhibitor

SETD2/KMT3A Inhibitors (2):

Cat. No. Product Name Effect Purity
  • HY-144858
    EZM0414
    Inhibitor 99.45%
    EZM0414 is a potent, selective, orally bioavailable inhibitor of SETD2 (IC50=18 nM in SETD2 biochemical assay; IC50=34 nM in cellular assay). EZM0414 can be used for the research of relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma.
  • HY-139626
    EPZ-719
    Inhibitor 99.85%
    EPZ-719 is a selective, orally effective SETD2 inhibitor with an IC50 value of 0.005 μM. EPZ-719 has anticancer activity.